Literature DB >> 191476

The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.

D B Glass, J M Gerrard, D Townsend, D W Carr, J G White, N D Goldberg.   

Abstract

Arachidonic acid- or collagen-induced aggregation was accompanied by a progressive elevation in the level of cyclic GMP in washed human platelets with no significant alteration in the concentration of cyclic AMP. The extent of the increase in cyclic GMP was proportional to the concentration of arachidonic acid added. Enhanced accumulation of cyclic GMP produced by arachidonic or collagen was prevented by prior exposure of platelets to aspirin or indomethacin. Prostaglandin endoperoxide G2 caused platelet aggregation and an increase in cyclic GMP concentration; neither event was blocked by prostaglandin synthesis inhibitors. These results indicate that the generation of prostaglandin endoperoxides is a step in the sequence of events in platelet aggregation leading to the enhanced accumulation of cyclic GMP.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191476

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  11 in total

1.  Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides.

Authors:  H Hidaka; T Asano
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Factors affecting the activity of guanylate cyclase in lysates of human blood platelets.

Authors:  A F Adams; R J Haslam
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

3.  Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation.

Authors:  C K Mittal; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens.

Authors:  C Spies; K D Schultz; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

5.  Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells.

Authors:  D G Cornwell; J J Huttner; G E Milo; R V Panganamala; H M Sharma; J C Geer
Journal:  Lipids       Date:  1979-02       Impact factor: 1.880

6.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Identification of 15-keto-9, 11-peroxidoprosta-5, 13- dienoic acid as a hematin-catalyzed decomposition product of 15-hydroperoxy-9, 11-peroxidoprosta-5, 13-dienoic acid.

Authors:  G Graff; E W Dunham; T P Krick; N D Goldberg
Journal:  Lipids       Date:  1979-04       Impact factor: 1.880

8.  Naphthalenes as inhibitors of myeloperoxidase: direct and indirect mechanisms of inhibition.

Authors:  R W Egan; W K Hagmann; P H Gale
Journal:  Agents Actions       Date:  1990-03

9.  N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Effect of vitamin A acid on cyclic nucleotides of cultured keratinocytes.

Authors:  D I Wilkinson; E K Orenberg
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.